期刊文献+

人前列腺特异性膜抗原基因重组腺病毒的构建及其表达

Construction and expression of recombinant adenovirus vector containing human prostate specific membrane antigen gene
下载PDF
导出
摘要 目的体外构建含有人前列腺特异性膜抗原(PSMA)基因的重组腺病毒载体,并检测其在HEK293细胞中的表达。方法设计一对含有SfiI酶切位点的PSMA基因上下游引物,以质粒pCMV-SPORT6/PSMA为模板,通过PCR扩增获得PSMA基因全序列。片段回收后经酶切处理,连接到穿梭质粒pShuttle-CMV-EGFP上,获得重组穿梭质粒pShuttle-EGFP-PSMA。经SfiI酶切、PCR及插入片段测序鉴定正确后,将其用I-CeuI和I-SceI双酶切处理,转移到pAdxsi载体上,得到pAdxsi-GFP-PSMA病毒质粒,线性化后经HEK293细胞包装成复制缺陷型腺病毒Ad-PSMA,通过观察绿色荧光蛋白(GFP)的表达,RT-PCR,Western印迹检测目的基因人PSMA的表达。结果成功构建了含有人PSMA基因的重组腺病毒,病毒滴度为2×1010 pfu/ml。Western印迹检测可见PSMA蛋白的正确表达。结论该重组腺病毒载体的成功构建及表达,为下一步以人PSMA作为靶抗原构建DC疫苗和基因免疫治疗奠定基础。 Objective To construct the recombinant adenovirus vector which containing human prostate specific membrane antigen(PSMA) gene and check the target gene expression in HEK293 cells.Methods Primers containing SfiⅠ was designed and full length PSMA cDNA was obtained from the pCMV-SPORT6/PSMA plasmid by PCR,the PCR product was digested with restrictive endonucleases SfiI,then being inserted directionally into pShuttle-CMV-EGFP.The plasmid of pShuttle-EGFP-PSMA was lined with SfiⅠ,the fragment containing PSMA was reclaimed and then transfected into pAdxsi vector after being digested with I-CeuI and I-SceI,the recombinant adenovirus plasmid was transfected into HEK293 and packed,and the expression of PSMA was proved by observing the green fluorescence protein(GFP) and detected by RT-PCR and Western blot method.Results The recombined adenovirus PSMA was constructed successfully and the titer was about 2×1010 pfu/ml.PSMA was expressed efficiently in HEK293 cells after infection.Conclusions The successful construction of recombinant adenovirus Ad-PSMA lays a good foundation for the further research on producing DC vaccines for the prostate cancer therapy.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第24期4864-4867,共4页 Chinese Journal of Gerontology
基金 辽宁省科技厅科学技术计划项目(2010225034)
关键词 腺病毒 基因表达 前列腺特异性膜抗原(PSMA) Adenovirus Gene expression Prostate specific membrane antigen(PSMA)
  • 相关文献

参考文献4

二级参考文献35

  • 1顾方六.前列腺增生和前列腺癌在中国发病情况的初步探讨[J].中华外科杂志,1993,31(6):323-326. 被引量:70
  • 2顾方六,山岗志,王通生,薛兆英.北京城乡良性前列腺增生发病的差异[J].中华泌尿外科杂志,1995,16(7):387-390. 被引量:61
  • 3王涛,王润田,顾方六,王天根,冷泰俊,汪启明,黄翼然,魏强,欧阳骏,甘为民,肖正文,高居忠,庞自力,张文标,朱江,赵长林,张元芳,刘雨,张力青,宋涛,高江平,王玉杰,段国兰,陈曾德.营养素的摄入水平与前列腺癌关系的病例对照研究[J].中华泌尿外科杂志,1996,17(9):540-544. 被引量:8
  • 4王润田,顾方六,王涛,Ann Hsing,冷泰俊,汪启明,黄翼然,魏强,欧阳骏,甘为民,肖正文,高居忠,庞自力,张文标,朱江,赵长林,张元芳,刘雨,张力青,宋涛,高江平,王玉杰,段国兰,陈曾德.性行为、癌前疾病与前列腺癌关系的病例对照研究[J].中华泌尿外科杂志,1996,17(8):481-487. 被引量:8
  • 5Dearnaley DP, Sydes MR, Graham JD, et al. Escalateddose versus standard-dose conformal radiotherapy in pros- tate cancer: first results from the MRC RT01 randomised controlled trial [ J ]. Lancet Oncol, 2007, 8 : 475 - 487.
  • 6Lubaroff DM, Konety B, Link BK, et al. Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer [ J ]. Hum Gene Ther, 2006, 17:220 -229.
  • 7Pantuck A J, Zisman A, Henderson D, et al. New biologicals for prostate cancer prevention: Genes, vaccines, and immune-based interventions [ J]. Urology, 2001,57:95 - 99.
  • 8Chang SS, Reuter VE, Heston WD, et al. Five different anti PSMA antibodies confirm prostate-specific membrane antigen (PSMA) expression intumor-associated neovasculature [J]. Cancer Res, 1999, 59:3192 -3198.
  • 9Rovenska M, Hlouchova K, Sacha P, et al. Tissue expression and enzymologic characterization of human prostate specific membrane antigen and its rat and pig orthologs [ J ]. Prostate, 2008, 68:171 - 182.
  • 10Olson WC, Heston WD, Rajasekaran AK. Clinical trials of cancer therapies targeting prostate-specific membrane antigen [J]. Rev Recent Clin Trials,2007, 2:152 -190.

共引文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部